Manyan Kamfanonin Magunguna 10 a Duniya

Bangaren harhada magunguna na daya daga cikin muhimman bangarorin da ba sa samar da kudaden shiga na biliyoyin daloli kuma baya tallafawa tattalin arzikin wani kamfani, amma wannan bangaren yana da nauyi mai girma na lafiyar dan Adam.

Su ma wadannan kamfanonin harhada magunguna kai tsaye ko a fakaice suna da hannu wajen magance cututtuka irin su kansar, HIV, hepatitis C da dai sauransu, yayin da sashen bincike da ci gaban wadannan kamfanoni ke samar da magunguna masu inganci don kawar da cututtukan da ke sama. Don haka, ga jerin manyan kamfanonin harhada magunguna guda goma na 2022 waɗanda ke taka muhimmiyar rawa wajen kyautata rayuwar ɗan adam.

10. Gileyad na Kimiyya | Amurka | Haraji: $24.474 biliyan.

Kimiyyar Gileyad wani kamfani ne na Amurka na biopharmaceutical wanda aka sani don haɓaka rigakafin ƙwayoyin cuta da sauran samfuran halittu. Kewayon su yawanci ya haɗa da magunguna don maganin cututtukan hanta, ciwon daji, HIV/AIDS da cututtukan zuciya. Ko da yake sun shahara sosai a kasuwa saboda maganin cutar hanta na C na Sovaldi. Michael L. Riordan ne ya kafa kamfanin a watan Yuni 1987 a Foster City, California, Amurka kuma yana da hedikwata a Foster City.

9. Bayer AG | Leverkusen, North Rhine-Westphalia, Jamus kudaden shiga: $25.47 biliyan

Friedrich Bayer da Johann Friedrich Weskott ne suka kafa kamfanin harhada magunguna da sinadarai na Jamus da yawa a duniya kimanin shekaru 153 da suka gabata a ranar 1 ga Afrilu, 1863. Kamfanin yana da hedkwatarsa ​​a Leverkusen, Jamus, amma ana rarraba samfuran su a duk duniya, gami da samfuran hanyoyin kiwon lafiya daban-daban kamar su Adempas na jijiyoyin bugun jini, Xofigo, magungunan ido Eylea, magungunan kansar Stivarga, da Xarelto anticoagulant. Bugu da kari, suna daya daga cikin mashahuran masu samar da sinadarai na noma tare da wasu 500 na magunguna da sinadarai.

8. AstraZeneca LLC | Birtaniya | Haraji: $26.095 biliyan

Kamfanin na Burtaniya-Sweden na kasa da kasa biopharmaceutical da kuma Pharmaceutical kamfanin sananne ne da kewayon kayayyakin a daban-daban kiwon lafiya yankunan kamar kumburi, numfashi cututtuka, neurological cuta, ciwon daji, gastrointestinal cututtuka da kuma zuciya da jijiyoyin jini cututtuka. Duk da yake samfuran da aka fi siyar da su suna cikin nau'ikan jiyya daban-daban kamar maganin oncology, ƙwannafi na ƙwannafi, Nexium na ciwon asma, Symbicort da maganin cholesterol na Crestor. Kamfanin yana da hedikwata a Cambridge, UK kuma yana da ma'aikata 55,000 da suke aiki a duk duniya.

7. GlaxoSmithKline | UK | Pharmaceuticals, generics da alluran rigakafi

An kafa GlaxoSmithKline Pharmaceuticals Limited a shekara ta 1924, wanda ya mai da ita mafi gogewar fasahar kere-kere a duniya kuma ɗaya daga cikin manyan kamfanonin bincike na kiwon lafiya da magunguna a duniya. Suna da nau'o'in samfura da yawa waɗanda ke ba da sabis a fannonin likita kamar ilimin likitancin mata, ciwon daji, cututtukan numfashi, cututtukan zuciya, cututtukan fata da rigakafin cututtuka. Suna kuma samun allurar rigakafin cutar sankarau, cututtuka, tetanus, rotavirus, asma, mura, hepatitis A, hepatitis B, cutar mahaifa da kuma kansa. A shekarar 36,566, jimillar kudaden shiga da kamfanin ya samu ya kai dalar Amurka miliyan 2015, inda aka zuba dalar Amurka miliyan 5441 a fannin bincike da ci gaba a wannan shekarar. Kamfanin yana da kasuwa mai girma a Japan da Indiya.

6. Merck & Co. Inc. | Amurka | Haraji: $42.237 biliyan.

An san Merck & Co inc don maganin ciwon daji Keytruda, wanda shine ɗayan magungunan FDA guda shida da aka amince da su tare da Belsomra don rashin barci da Zerbaxa & Cubist don cututtuka na asibiti. A cewar wani rahoto na 2014, sashen bincike na Merck ya fitar da sabbin magunguna fiye da kowane kamfani a duniya. Merck & Co ya shahara a tsakanin ɗaliban likitanci don mafi kyawun siyar da jerin littattafan tunani, The Merck Manuals.

5. Sanofi| Faransa | Haraji: $43.07 biliyan.

Ɗaya daga cikin manyan kamfanonin samar da magunguna na Faransa da ke da kuɗin shiga na dala biliyan 43.07. An san kamfanin da magungunan sayan magani da kuma kan-da-counter (OTC) a wuraren warkewa kamar alluran rigakafi, thrombosis, cututtukan zuciya, magungunan ciki, tsarin juyayi na tsakiya da ciwon sukari. Ganin cewa Lantus, mai kashe ciwon sukari, yana da kaso mafi girma na jimlar kuɗin da kamfanin ya samu. Jean-Francois Dehaek da Jean-René Sautier ne suka kafa Ƙungiyar Sanofi kuma a halin yanzu suna da mafi girma (110,000) ma'aikata don samar da ayyukansu a duk duniya.

4. Pfizer| New York, Amurka | Haraji: $49.605 biliyan

Kamfani na huɗu mafi girma a cikin masana'antar harhada magunguna a duniya, wanda aka sani da samfuran biopharmaceutical, gami da magunguna na fannoni daban-daban na likitanci: ilimin zuciya, oncology da rigakafi. Kayayyakinsu na yau da kullun da na halitta sun sami ci gaban tallace-tallace bayan dala biliyan 17 da suka samu na kamfanin Hospira na allura. Charles Pfizer ne ya kafa kamfanin a 1849 a Brooklyn, New York, New York, Amurka. Kamfanin yana da fiye da ma'aikata 96,000, hedkwatar bincike a Groton, Connecticut, da hedkwatar kamfanoni na magunguna a New York, Amurka.

3. Roche Holding AG | Basel, Switzerland | Haraji: $49.86 biliyan

Kamfani na biyu mafi girma na harhada magunguna a Switzerland kuma na uku mafi girma na kamfanonin harhada magunguna a duniya, an san shi da mafita na musamman na bincike da kayan aikin bincike na sama. Har ila yau, kamfanin ya shahara sosai ga magungunan da ake siyar da su kamar su Xeloda, Herceptin, Avastin da magungunan kansar MebThera. Haka kuma, sabuwar dabarar rigakafin cutar sankarar mahaifa ta Roche ita ce mafi kyawun mafita da ake samu a yau, musamman ga mata. Fritz Hoffmann-La Roche ne ya kafa kamfanin kuma a halin yanzu yana aiki a sassa biyu da ake kira Roche Pharmaceutical da Roche Diagnostics, tare da ma'aikata sama da 95,000 a duk duniya.

2. Novartis AG | Switzerland | Haraji: $57.996 biliyan

Tare da kudaden shiga na dalar Amurka biliyan 54.996, Novartis AG tana matsayi na biyu a jerin manyan kamfanonin harhada magunguna. Novartis shine babban kamfanin harhada magunguna a Switzerland, wanda ya kware a fannin ilimin halittu (Gleevec for cancer and Gilenya for multiple sclerosis). Kamfanin ya ƙunshi sassa da yawa kamar kulawar ido, biosimilars, generics da magunguna, tare da dakunan gwaje-gwaje sama da 140 da ma'aikata 100,000 a duk duniya. Kamfanin shine kamfani na biyu mafi girma a cikin masana'antar harhada magunguna a duniya tare da nau'ikan hanyoyin magance lafiya da bincike da haɓaka don gaba.

1. Johnson & Johnson | Amurka | Haraji: $74.331 biliyan.

Sunan dangin Johnson da Johnson yana kan gaba a jerin mafi kyawun kamfanonin harhada magunguna a duniya kasancewar shi ne na biyu mafi tsufa kuma mafi gogaggen kamfani. J & J aka Johnson da Johnson sun kafa Woodn Johnson I, James Wood Johnson da Edward Mead Johnson a 1886. Kamfanin a halin yanzu yana ba da samfuran kiwon lafiya da yawa, waɗanda suka haɗa da sabulu, masu tsaftacewa, talc, da Johnson & Johnson. yana da fiye da 182 sayar da kayayyakin a fannoni daban-daban na magani ga cututtuka na narkewa kamar fili, hepatitis C da amosanin gabbai. Kamfanin yana ba da sabis ɗin sa don samfuran kiwon lafiya da yawa a duk duniya. Johnsons da Johnsons sun shahara sosai don samfuran kula da jarirai a Amurka da sauran ƙasashen Asiya.

Akwai wasu kamfanonin harhada magunguna da yawa irin su Zydus Cadila, Siemens da Thermo fisher waɗanda su ma sun ba da gudummawar jin daɗin ɗan adam. Amma kamfanonin da ke sama sun fi kyau ta fuskar bincike, aiki, canji da kuma bayar da sabis a duniya. Su ma wadannan kamfanoni suna da alhakin kawar da rabin cututtuka masu hatsarin gaske. Wadannan kamfanoni sune ainihin abin da ke haifar da rudani na gaba na zamanin ɗan adam.